Exakte Wirkstoffkennungen und zitierbare Passagen zu Wechselwirkungen, Gegenanzeigen und Nebenwirkungen.
Ein Paarvergleich findet Originalpassagen, die den anderen Wirkstoff wörtlich nennen. Aussagen gelten für das jeweilige Präparat und seine Formulierung. Klassenbegriffe und abweichende Synonyme können fehlen. Kein Treffer bedeutet nicht, dass keine Wechselwirkung besteht.
Pooling of the following classes of antihypertensive medicinal products: diuretics, beta-blockers, ACE
inhibitors, angiotensin II antagonists, antihypertensive medicinal products (vasodilator and
centrally-acting), adrenergic neurone blockers, calcium channel blockers and alpha-adrenoceptor
blockers, showed no difference in the side effect profile in patients taking sildenafil compared to
placebo treatment. In a specific interaction study, where sildenafil (100 mg) was co-administered with
amlodipine in hypertensive patients, there was an additional reduction on supine systolic blood
pressure of 8 mmHg. The corresponding additional reduction in supine diastolic blood pressure was
7 mmHg. These additional blood pressure reductions were of a similar magnitude to those seen when
sildenafil was administered alone to healthy volunteers (see section 5.1).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Pooling of the following classes of antihypertensive medicinal products: diuretics, beta-blockers, ACE
inhibitors, angiotensin II antagonists, antihypertensive medicinal products (vasodilator and
centrally-acting), adrenergic neurone blockers, calcium channel blockers and alpha-adrenoceptor
blockers, showed no difference in the side effect profile in patients taking sildenafil compared to
placebo treatment. In a specific interaction study, where sildenafil (100 mg) was co-administered with
amlodipine in hypertensive patients, there was an additional reduction on supine systolic blood
pressure of 8 mmHg. The corresponding additional reduction in supine diastolic blood pressure was
7 mmHg. These additional blood pressure reductions were of a similar magnitude to those seen when
sildenafil was administered alone to healthy volunteers (see section 5.1).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Pooling of the following classes of antihypertensive medicinal products: diuretics, beta-blockers, ACE
inhibitors, angiotensin II antagonists, antihypertensive medicinal products (vasodilator and
centrally-acting), adrenergic neurone blockers, calcium channel blockers and alpha-adrenoceptor
blockers, showed no difference in the adverse events profile in patients taking sildenafil compared to
placebo treatment. In a specific interaction study, where sildenafil (100 mg) was co-administered with
amlodipine in hypertensive patients, there was an additional reduction on supine systolic blood
pressure of 8 mmHg. The corresponding additional reduction in supine diastolic blood pressure was
7 mmHg. These additional blood pressure reductions were of a similar magnitude to those seen when
sildenafil was administered alone to healthy volunteers (see section 5.1).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Version 2026-10-13T10:49:00Z · SHA-256 6ad3c46b09a0a4a504f9373ab6370260a3b70fd305f7a7b80959175ca84b454e · Passage c9df0cb057c00453d6e0d646d0e25adb55dc638154ceccc0e29d647a75350580 · Zeichen 7002–7866 im Abschnitt
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.